STAGE I BREAST CANCER AJCC V7
Clinical trials for STAGE I BREAST CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE I BREAST CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE I BREAST CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough breast cancers: 3-Drug combo tested before surgery
Disease control CompletedThis study tested whether adding a targeted drug (panitumumab) to two standard chemotherapy drugs could shrink tumors before surgery in patients with triple-negative breast cancer. The treatment was specifically for patients whose cancer didn't respond well to initial chemotherap…
Matched conditions: STAGE I BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Smart bottles & video calls aim to keep cancer patients on track
Disease control CompletedThis study tested whether using technology could help breast cancer patients stick to their long-term hormone therapy after surgery. Researchers compared standard doctor visits to two tech-based approaches: one using automated symptom surveys with follow-up video calls, and anoth…
Matched conditions: STAGE I BREAST CANCER AJCC V7
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Three-drug combo tested to stop early breast cancer from coming back
Disease control CompletedThis study tested a combination of three drugs given after surgery for early-stage HER2-positive breast cancer. The goal was to see if this treatment could help prevent the cancer from returning and to understand its side effects. It involved 20 patients who received the drug reg…
Matched conditions: STAGE I BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC